Connectome architecture, gene expression and functional co-activation shape the propagation of misfolded proteins in neurodegenerative disease

It is becoming increasingly clear that brain network organization shapes the course and expression of neurodegenerative diseases. Parkinson’s disease (PD) is marked by progressive spread of atrophy from the midbrain to subcortical structures and eventually, to the cerebral cortex. Recent discoveries suggest that the neurodegenerative process involves the misfolding of endogenous proteins (α-synuclein) and prion-like spread of these pathogenic proteins via axonal projections. However, the mechanisms that translate local “synucleinopathy” to large-scale network dysfunction and atrophy remain unknown. Here we use an agent-based epidemic spreading model to integrate structural connectivity, functional connectivity and gene expression, and to predict sequential volume loss due to neurodegeneration. We demonstrate three key findings. First, the dynamic model replicates the spatial distribution of empirical atrophy identified in an independent dataset of PD patients. Second, the model implicates the substantia nigra as the disease epicenter, consistent with previous literature. Third, we reveal a significant role for both connectome topology and spatial embedding (geometry) in shaping the distribution of atrophy. Gene expression and functional co-activation further amplify the course set by connectome architecture. Altogether, these results support the notion that the progression of neurodegenerative disease is a multifactorial process that depends on both cell-to-cell spreading of misfolded proteins and local regional vulnerability. The model proves powerful in modelling neurodegeneration and provides insights into developing preventative procedures.

[1]  J. Morrison,et al.  The aging brain: morphomolecular senescence of cortical circuits , 2004, Trends in Neurosciences.

[2]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[3]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[4]  Alessandro Flammini,et al.  Optimal network clustering for information diffusion , 2014, Physical review letters.

[5]  M. Giugliano,et al.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.

[6]  J. Trojanowski,et al.  Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term , 2017, Acta Neuropathologica.

[7]  P. Brundin,et al.  Prying into the Prion Hypothesis for Parkinson's Disease , 2017, The Journal of Neuroscience.

[8]  D. James Surmeier,et al.  Selective neuronal vulnerability in Parkinson disease , 2017, Nature Reviews Neuroscience.

[9]  Vanessa Frías-Martínez,et al.  An Agent-Based Model of Epidemic Spread Using Human Mobility and Social Network Information , 2011, 2011 IEEE Third Int'l Conference on Privacy, Security, Risk and Trust and 2011 IEEE Third Int'l Conference on Social Computing.

[10]  Masato Hasegawa,et al.  Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.

[11]  J. Trojanowski,et al.  Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.

[12]  Richard F. Betzel,et al.  Modular Brain Networks. , 2016, Annual review of psychology.

[13]  A. Dagher,et al.  Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.

[14]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[15]  S. Xie,et al.  Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity , 2018, Acta Neuropathologica.

[16]  Alan C. Evans,et al.  Network structure of brain atrophy in de novo Parkinson's disease , 2015, eLife.

[17]  W. Jackson Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein , 2014, Disease Models & Mechanisms.

[18]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[19]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[20]  Fang-Cheng Yeh,et al.  NTU-90: A high angular resolution brain atlas constructed by q-space diffeomorphic reconstruction , 2011, NeuroImage.

[21]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[22]  D. Cleveland,et al.  Prion-like spread of protein aggregates in neurodegeneration , 2012, The Journal of experimental medicine.

[23]  Alessandro Flammini,et al.  Erratum: Optimal Network Modularity for Information Diffusion [Phys. Rev. Lett. 113, 088701 (2014)] , 2014 .

[24]  Mathias Jucker,et al.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.

[25]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[26]  Daniel S. Margulies,et al.  Tight fitting genes: finding relations between statistical maps and gene expression patterns , 2014 .

[27]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[28]  H. Braak,et al.  100 years of Lewy pathology , 2013, Nature Reviews Neurology.

[29]  Alan C. Evans,et al.  Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders , 2014, PLoS Comput. Biol..

[30]  O. Sporns,et al.  High-cost, high-capacity backbone for global brain communication , 2012, Proceedings of the National Academy of Sciences.

[31]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[32]  E. Hirsch,et al.  Understanding Dopaminergic Cell Death Pathways in Parkinson Disease , 2016, Neuron.

[33]  Pierrick Coupé,et al.  An Optimized Blockwise Nonlocal Means Denoising Filter for 3-D Magnetic Resonance Images , 2008, IEEE Transactions on Medical Imaging.

[34]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[35]  M. Neunlist,et al.  Activity‐dependent secretion of alpha‐synuclein by enteric neurons , 2013, Journal of neurochemistry.

[36]  Essa Yacoub,et al.  The WU-Minn Human Connectome Project: An overview , 2013, NeuroImage.

[37]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[38]  John Q Trojanowski,et al.  Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease , 2016, The Journal of experimental medicine.

[39]  Patric Hagmann,et al.  Mapping the human connectome at multiple scales with diffusion spectrum MRI , 2012, Journal of Neuroscience Methods.

[40]  G. Halliday,et al.  Neuropathology of α‐synuclein propagation and braak hypothesis , 2016, Movement disorders : official journal of the Movement Disorder Society.

[41]  M. Newman,et al.  Epidemics and percolation in small-world networks. , 1999, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[42]  Fernando Calamante,et al.  The contribution of geometry to the human connectome , 2016, NeuroImage.

[43]  K. Sneppen,et al.  Specificity and Stability in Topology of Protein Networks , 2002, Science.

[44]  E. Bullmore,et al.  The hubs of the human connectome are generally implicated in the anatomy of brain disorders , 2014, Brain : a journal of neurology.

[45]  Ellen Sidransky,et al.  The link between the GBA gene and parkinsonism , 2012, The Lancet Neurology.

[46]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[47]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[48]  D. Louis Collins,et al.  Animal: Validation and Applications of Nonlinear Registration-Based Segmentation , 1997, Int. J. Pattern Recognit. Artif. Intell..

[49]  E. Kuhl,et al.  Multiphysics of Prionlike Diseases: Progression and Atrophy. , 2018, Physical review letters.

[50]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[51]  Alessandro Vespignani,et al.  Modeling the spatial spread of infectious diseases: The GLobal Epidemic and Mobility computational model , 2010, J. Comput. Sci..

[52]  Vladimir S Fonov,et al.  Network connectivity determines cortical thinning in early Parkinson’s disease progression , 2017, Nature Communications.

[53]  Olaf Sporns,et al.  Network-Based Asymmetry of the Human Auditory System , 2018, bioRxiv.

[54]  Timothy D. Verstynen,et al.  Deterministic Diffusion Fiber Tracking Improved by Quantitative Anisotropy , 2013, PloS one.

[55]  Olaf Sporns,et al.  Complex network measures of brain connectivity: Uses and interpretations , 2010, NeuroImage.

[56]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[57]  D. Selkoe,et al.  A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration , 2016, Nature Reviews Neuroscience.

[58]  E. Morignat,et al.  Prion-like acceleration of a synucleinopathy in a transgenic mouse model , 2012, Neurobiology of Aging.

[59]  Jeffrey H Kordower,et al.  Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy. , 2012, Progress in brain research.

[60]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[61]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[62]  Marcus Kaiser,et al.  Clustered organization of cortical connectivity , 2007, Neuroinformatics.

[63]  J. Aharon-Peretz,et al.  Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2004, The New England journal of medicine.

[64]  Leonardo L. Gollo,et al.  Fragility and volatility of structural hubs in the human connectome , 2018, Nature Neuroscience.

[65]  Fang-Cheng Yeh,et al.  Generalized ${ q}$-Sampling Imaging , 2010, IEEE Transactions on Medical Imaging.

[66]  W. Chung,et al.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. , 2015, Brain : a journal of neurology.

[67]  Richard F. Betzel,et al.  Distance-dependent consensus thresholds for generating group-representative structural brain networks , 2019, Network Neuroscience.

[68]  V. Lee,et al.  Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases , 2014, Nature Medicine.

[69]  Heidi Johansen-Berg,et al.  Tractography: Where Do We Go from Here? , 2011, Brain Connect..

[70]  Max C. Keuken,et al.  Quantifying inter-individual anatomical variability in the subcortex using 7T structural MRI , 2014, NeuroImage.

[71]  Mark Newman,et al.  Networks: An Introduction , 2010 .

[72]  Richard F. Betzel,et al.  Cooperative and Competitive Spreading Dynamics on the Human Connectome , 2015, Neuron.

[73]  Andrew Zalesky,et al.  Navigation of brain networks , 2018, Proceedings of the National Academy of Sciences.

[74]  J. Trojanowski,et al.  Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.

[75]  D. Helbing,et al.  The Hidden Geometry of Complex, Network-Driven Contagion Phenomena , 2013, Science.

[76]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[77]  A. Dagher,et al.  Anatomical and functional organization of the human substantia nigra and its connections , 2017, bioRxiv.